Quoin Pharmaceuticals Analyst Ratings
Quoin Pharmaceuticals Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 09/07/2022 | 502.41% | Alliance Global Partners | → $20 | Initiates Coverage On | → Buy |
| 05/06/2022 | -39.76% | Ladenburg Thalmann | → $2 | Initiates Coverage On | → Buy |
| 01/07/2022 | 50.6% | Maxim Group | → $5 | Initiates Coverage On | → Buy |
| 12/15/2021 | 140.96% | JMP Securities | → $8 | Initiates Coverage On | → Market Outperform |
| 日期 | 上行/下行 | 分析公司 | 目標價格變化 | 評級變化 | 上一次/當前評級 |
|---|---|---|---|---|---|
| 09/07/2022 | 502.41% | 聯盟全球合作伙伴 | → $20 | 開始承保 | →購買 |
| 05/06/2022 | -39.76% | 拉登堡·塔爾曼 | → $2 | 開始承保 | →購買 |
| 01/07/2022 | 50.6% | Maxim集團 | → $5 | 開始承保 | →購買 |
| 12/15/2021 | 140.96% | JMP證券 | → $8 | 開始承保 | →市場跑贏大盤 |
Quoin Pharmaceuticals Questions & Answers
Quoin PharmPharmticals問答
The latest price target for Quoin Pharmaceuticals (NASDAQ: QNRX) was reported by Alliance Global Partners on September 7, 2022. The analyst firm set a price target for $20.00 expecting QNRX to rise to within 12 months (a possible 502.41% upside). 4 analyst firms have reported ratings in the last year.
Quoin製藥(納斯達克：QNRX)的最新目標價是由Alliance Global Partners於2022年9月7日報道的。這家分析公司將目標價定為20美元，預計QNRX將在12個月內上漲(可能上漲502.41%)。去年有4家分析公司公佈了評級。
The latest analyst rating for Quoin Pharmaceuticals (NASDAQ: QNRX) was provided by Alliance Global Partners, and Quoin Pharmaceuticals initiated their buy rating.
納斯達克(Sequoia Capital：QNRX)的最新分析師評級由Alliance Global Partners提供，Quoin PharmPharmticals啟動了他們的買入評級。
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Quoin Pharmaceuticals, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Quoin Pharmaceuticals was filed on September 7, 2022 so you should expect the next rating to be made available sometime around September 7, 2023.
分析師在進行了廣泛的研究後得出股票評級，其中包括查閲公共財務報表，與Quoin PharmPharmticals的高管和客户交談，以及聽取收益電話會議。大多數分析師每三個月就會這樣做一次，所以你每年應該會得到每家公司每家公司的4個評級。Quoin製藥的上一次評級是在2022年9月7日提交的，所以你應該預計下一次評級將在2023年9月7日左右的某個時候公佈。
While ratings are subjective and will change, the latest Quoin Pharmaceuticals (QNRX) rating was a initiated with a price target of $0.00 to $20.00. The current price Quoin Pharmaceuticals (QNRX) is trading at is $3.32, which is within the analyst's predicted range.
雖然評級是主觀的，並將發生變化，但最新的Quoin PharmPharmticals(QNRX)評級是以0.00美元至20.00美元的目標價啟動的。Quoin PharmPharmticals(QNRX)目前的交易價格為3.32美元，在分析師的預測範圍內。